Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Allende

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Revista Clinica Espanola|March 1, 1991
[Simultaneous assay of SLX and CEA does not increase the clinical usefulness of the latter in patients with colorectal carcinoma]M C Roiz, M T Allende, J Vivanco, et al.
Medicina Clinica|March 3, 1990
[Correlation of serum concentrations of BCM and MCA, CA 549 and CA 15.3 in women with macrocystic disease of breast]F Vizoso, M C Roiz, M T Allende, et al.
The International Journal of Biological Markers|January 1, 1991
Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathyF Vizoso, M T Allende, M C Diez, et al.
Revista Clinica Espanola|November 1, 1990
[The existence of a correlation between the serum values of MCA and CA 15.3 in patients with digestive tumors]M C Roiz, F Vizoso, M T Allende, et al.
Revista Clinica Espanola|October 1, 1992
[Cytosol concentrations of CAM29 in breast carcinoma. Effect of the pS2]B Suárez, B Fernández Llana, M T Allende, et al.
Revista Clinica Espanola|November 1, 1991
[Correlation between blood concentrations of CA 15.3 and estradiol in women with macrocystic disease of breast. Study in function of the type of cyst]F Vizoso, M T Allende, M C Díez, et al.
Revista Clinica Espanola|October 1, 1992
[Cytosolic oncogenic neu protein determined with enzyme immunoassay: approximation to a marker of clinical application]M T Allende, M Fernández Fernández, B Fernández Llana, et al.
Revista Clinica Espanola|March 1, 1992
[Preliminary experience with BCM-IMx as a pretreatment marker of breast tumors]B Fernández Llana, M Fernández Fernández, B Suárez, et al.
The International Journal of Biological Markers|January 1, 1990
Correlation between BCM (breast cancer mucin) and CA 549 serum levels cystic breast diseaseM T Allende, F Vizoso, M C Roiz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Quantification and molecular analysis of cathepsin D in breast cyst fluidsL M Sánchez, F Vizoso, M T Allende, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Revista Clinica Espanola|March 1, 1991
[Simultaneous assay of SLX and CEA does not increase the clinical usefulness of the latter in patients with colorectal carcinoma]M C Roiz, M T Allende, J Vivanco, et al.
Medicina Clinica|March 3, 1990
[Correlation of serum concentrations of BCM and MCA, CA 549 and CA 15.3 in women with macrocystic disease of breast]F Vizoso, M C Roiz, M T Allende, et al.
The International Journal of Biological Markers|January 1, 1991
Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathyF Vizoso, M T Allende, M C Diez, et al.
Revista Clinica Espanola|November 1, 1990
[The existence of a correlation between the serum values of MCA and CA 15.3 in patients with digestive tumors]M C Roiz, F Vizoso, M T Allende, et al.
Revista Clinica Espanola|October 1, 1992
[Cytosol concentrations of CAM29 in breast carcinoma. Effect of the pS2]B Suárez, B Fernández Llana, M T Allende, et al.
Revista Clinica Espanola|November 1, 1991
[Correlation between blood concentrations of CA 15.3 and estradiol in women with macrocystic disease of breast. Study in function of the type of cyst]F Vizoso, M T Allende, M C Díez, et al.
Revista Clinica Espanola|October 1, 1992
[Cytosolic oncogenic neu protein determined with enzyme immunoassay: approximation to a marker of clinical application]M T Allende, M Fernández Fernández, B Fernández Llana, et al.
Revista Clinica Espanola|March 1, 1992
[Preliminary experience with BCM-IMx as a pretreatment marker of breast tumors]B Fernández Llana, M Fernández Fernández, B Suárez, et al.
The International Journal of Biological Markers|January 1, 1990
Correlation between BCM (breast cancer mucin) and CA 549 serum levels cystic breast diseaseM T Allende, F Vizoso, M C Roiz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Quantification and molecular analysis of cathepsin D in breast cyst fluidsL M Sánchez, F Vizoso, M T Allende, et al.
Pageof 8